Clinical Study of Transurethral Enucleation of the Prostate in the Treat-ment of Benign Prostatic Hyperplasia
Objective To explore the clinical efficacy of trans urethral enucleation prostate(TUEP)in the treatment of benign prostatic hyperplasia(BPH).Methods A total of 88 patients with BPH admitted to Youxi County General Hos-pital from January 2021 to January 2024 were conveniently selected as the research objects.They were divided into control group(n=44)and study group(n=44)by random number table method.The control group was treated with trans urethral resection prostate,and the study group was treated with TUEP.The perioperative indexes,serum inflam-matory factors,complications and urodynamics index were compared between the two groups.Results The operation time of the study group was shorter than that of the control group,the intraoperative blood loss and postoperative drain-age volume were less,and the resected tissue was heavier,the differences were statistically significant(all P<0.05).The levels of tumor necrosis factor-α and C-reactive protein in patients in two groups increased at 1 d after operation,but those in the study group were lower than those in the control group,and the differences were statistically signifi-cant(t=11.073,10.830,all P<0.05).The total incidence of postoperative complications in the study group(4.55%)was lower than that in the control group(22.73%),and the difference was statistically significant(χ2=6.175,P<0.05).One month after operation,the residual urine volume decreased and the maximum urinary flow rate increased in patients in two groups,and the study group was better than the control group,the difference was statistically significant(all P<0.05).Conclusion TUEP treatment for BPH patients can improve resection rate,improve perioperative indicators,con-trol postoperative inflammatory response,reduce the incidence of complications,and promote improvement in urody-namics.
NETL
NSTL
万方数据
